High-Density Lipoprotein Cholesterol: Methods and Clinical Significance

References

• Steinberg D. The rediscovery of high density lipoprotein: a negative risk factor in atherosclerosis. Europ. J. Clin. Invest. 1978; 8: 107
   PubMed Web of Science ®Google Scholar
• Eisenberg S. Relationship of HDL to other lipoproteins. High Density Lipoproteins and Atherosclerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier/North Holland, Amsterdam 1978; 67
   Google Scholar
• Havel R. J. Origin of HDL. High Density Lipoproteins and Atherosclerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier/North Holland, Amsterdam. 1978; 21
   Google Scholar
• Nikkilä E. A. Metabolic and endoscrine control of plasma high density lipoprotein concentration. Relation to catabolism of triglyceride-rich lipoproteins. High Density Lipoproteins and Atherosclerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier/North Holland, Amsterdam 1978; 177
   Google Scholar
• Pownall H. J., Sparrow J. T., Gotio A. M. High density apolipoprotein structure and function. High Density Lipoproteins and Atherosclerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier/North Holland, Amsterdam 1978; 5
   Google Scholar
• Stein Y., Stein O., Goren R. Metabolism and metabolic role of serum high density lipoproteins. High Density Lipoproteins and Atherosclerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier/North Holland, Amsterdam 1978; 37
   Google Scholar
• Witztum J., Schonfeld G. High density lipoproteins. Diabetes 1979; 28: 326
   PubMed Web of Science ®Google Scholar
• Miller G. J. High density lipoproteins and atherosclerosis. Ann. Rev. Med. 1980; 31: 97
   PubMed Web of Science ®Google Scholar
• Heiss G., Johnson N. J., Reiland S., Davis C. E., Tyroler H. A. The epidemiology of plasma high-density lipoprotein cholesterol levels. Lipid Res. Clin. Program Prevalence Study Summary Circ. 1980; 62(Suppl IV)116
   Google Scholar
• Havel R. J. Lipoprotein biosynthesis and metabolism. Ann. N. Y. Acad. Sci. 1980; 348: 16
   PubMedGoogle Scholar
• Havel R. J., Goldstein J. L., Brown M. S. Lipoproteins and lipid transport. Metabolic Control and Disease, P. K. Bondy, L. E. Rosenberg. W.B. Saunders., Philadelphia 1980; 393
   Google Scholar
• Glomset J. A. High-density lipoproteins in human health and disease. Ann. Rev. Med. 1980; 31: 91
   Web of Science ®Google Scholar
• Miller J. P., Gotto A. M. The plasma lipoproteins: their formation and metabolism. Comprehensive Biochemistry. Florkin, M., Stotz, E. Vol. 19B, In press
   Google Scholar
• Macheboeuf M., Rebeyrotte P. Studies on lipo-protein cenapses of horse serum. Discuss. Faraday Soc. 1949; 6: 62
   Google Scholar
• Barr D. P., Russ E. M., Eder H. A. Protein-lipid relationships in human plasma. II. In Atherosclerosis and related conditions. Am. J. Med. 1951; II: 480
   Google Scholar
• Nikkilä E. Studies on the lipid-protein relationships in normal and pathological sera and the effect of heparin on serum lipoprotein. Scand. J. Clin. Lab. Invest. 1953; 5(Suppl.)1
   Google Scholar
• Jencks W. P., Hyatt M. R., Jetton M. R., Mattingly T. W., Durrum E. L. A study of serum lipoproteins in normal and atherosclerotic patients by paper electrophoretic techniques. J. Clin. Invest. 1956; 9: 980
   Google Scholar
• Brunner D., Lobl K. Serum cholesterol electrophoretic lipid pattern diet and coronary artery disease: a study in coronary patients and in healthy men of different origin and occupations in Israel. Ann. Int. Med. 1958; 49: 732
   PubMed Web of Science ®Google Scholar
• Dodds C., Mills G. L. Influence of myocardial infarction on plasma-lipoprotein concentration. Lancet 1959; I: 1160
   Google Scholar
• Gofman J. W., DeLalla O., Glazier F., Freeman N. K., Lindgren F. T., Nichols A. V., Strisower B., Tamplin A. R. The serum lipoprotein transport system in health, metabolic diseases. atherosclerosis and coronary heart disease. Plasma 1954; 2: 413
   Google Scholar
• Gofman J. W., Young W., Tandy R. Ischemic heart disease. Atherosclerosis, and longevity. Circulation 1966; 34: 679
   PubMed Web of Science ®Google Scholar
• Miller G. J., Miller N. E. Plasma high density lipoprotein concentration and development of ischaemic heart disease. Lancet 1975; I: 16
   Google Scholar
• Wiklund O., Gustafson A., Wilhelmsen L. A-lipoprotein cholesterol in men after myocardial infarction compared with a population sample. Artery 1975; 1: 399
   Google Scholar
• Rhoads G. G., Gulbrandsen C. L., Kagan A. Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N. Engl. J. Med. 1976; 294: 293
   PubMed Web of Science ®Google Scholar
• Ononogbu L. C. High density lipoproteins in ischaemic heart disease. Experientia 1976; 33: 1063
   Google Scholar
• Miller G. J. Miller, N. E., Ashcroft, M. T., Inverse relationship in Jamaica between plasma high-density lipoprotein cholesterol concentration and coronary-disease risk as predicted by multiple risk-factor status. Clin. Sci. Mol. Med. 1976; 51: 475
   PubMedGoogle Scholar
• Castelli W. P, Doyle J. T., Gordon T., Hames C. G., Hjortland M. C, Hulley S. B., Kagan A., Zukel W. J. HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 1977; 55: 767
   PubMed Web of Science ®Google Scholar
• Albers J. J., Cheung M. C, Hazzard YV. High-density lipoproteins in myocardial infarction survivors. Metabolism 1978; 27: 479
   PubMed Web of Science ®Google Scholar
• Jenkins P. J., Harper R. W., Nestel P. J. Severity of coronary atherosclerosis related to lipoprotein concentration. Br. Med. J. 1978; 2: 388
   PubMed Web of Science ®Google Scholar
• Avogaro P., Butolobon G., Cazzolato G., Quinci G. B. Are apolipoproteins better discriminators than lipids for atherosclerosis?. Lancet 1979; i: 901
   Google Scholar
• Noma A., Matsushita S., Komori T., Abe K., Okabe H., Kuramoto K., Murakami M. H igh and low density lipoprotein cholesterol in myocardial and cerebral infarction. Atherosclerosis 1979; 32: 327
   PubMed Web of Science ®Google Scholar
• Pearson T. A., Bulkley B. H., Achuff S. C, Kwiterovich P. O., Cordis L. The association of low levels of HDL cholesterol and arteriographically defined coronary artery disease. Am. J. Epidemiol. 1979; 109: 285
   PubMed Web of Science ®Google Scholar
• Tan M. H., Macintosh W., Weldon K. L., Kapoor A., Chandler B. M., Hindmarsh T. J. Serum high density lipoprotein cholesterol in patients with abnormal coronary arteries. Atherosclerosis. 1980; 37: 187
   PubMed Web of Science ®Google Scholar
• Miller N. E., Hammelt F., Saltissi S., Rao S., van Zeller H., Coltart J., Lewis B. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipopro-teins. Br. Med. J. 1981; 22: 1741
   Google Scholar
• Miller N. E., Fôrde O. H., Thelle D. S., Mjôs O. D. The Tr0mso heart study. High-density-lipoprotein and coronary heart disease in a prospective case-control study. Lancet 1977; i: 965
   Web of Science ®Google Scholar
• Gordon T., Castelli W. P., Hjortland M. C, Kannel W. B., Dawber T. R. High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med. 1977; 62: 707
   PubMed Web of Science ®Google Scholar
• Goldbourt V., Medalie J. H. High density lipoprotein cholesterol and incidence of coronary heart disease. The Israeli lschaemic Heart Disease Study. Am. J. Epidemiol. 1979; 109: 296
   PubMed Web of Science ®Google Scholar
• Yaari S., Goldbourt U., Even-Zohar S., Neufeld H. N. Associations of serum high density lipoprotein and total cholesterol with total cardiovascular, and cancer mortality in a 7-year prospective study of 10,000 men. Lancet 1981; i: 1011
   Google Scholar
• Rössner S., Kjeilin K. G., Mettinger K. L., Sidén A., Sbderstrom C. E. Normal serum-cholesterol but low HDL-cholesterol concentration in young patients with ischaemic cerebrovascular disease. Lancet 1978; i: 577
   Google Scholar
• Rössner S., Kjeilin K. G., Mettinger K. L., Sidén A., Söderstrü C. E. Dyslipoproteinaemia in patients with ischemic cerebrovascular disease. A study of stroke before the age of 55. Atherosclerosis. 1978; 30: 199
   PubMed Web of Science ®Google Scholar
• Sirtori C. R, Gianfraneschi G., Gritti I., Nappi G., Brambilla G., Paoletti P. Decreased high density lipoprotein-cholesterol levels in male patients with transient ischemic attacks. Atherosclerosis. 1978; 32: 205
   Web of Science ®Google Scholar
• Toggart H., Stout R. W. Reduced high density lipoprotein in stroke: relationship with elevated triglyceride and hypertension. Eur. J. Clin. Invest. 1979; 9: 219
   PubMed Web of Science ®Google Scholar
• Bradby G. V. H., Valente A. J., Walton K. W. Serum high-density lipoproteins in peripheral vascular disease. Lancet 1978; ii: 1271
   Google Scholar
• Meeploo J. M., Billimoria J. D. High density lipoprotein levels in peripheral vascular disease and in women on oral contraception. Atherosclerosis. 1979; 33: 267
   PubMed Web of Science ®Google Scholar
• Trayner I. M., Mannarino E., Clyne C. A., Thompson G. R. Serum lipids and high density lipoprotein cholesterol in peripheral vascular disease. Br. J. Surg. 1980; 67: 497
   PubMed Web of Science ®Google Scholar
• Albers J. J., Hazzard W. R. Immunochemical quantification of human plasma Lp(a) Lipoprotein. Lipids 1974; 9: 15
   PubMed Web of Science ®Google Scholar
• Anderson D. W, Nichols A. V., Pan S. S., Lindgren F. T. High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample. Atherosclerosis. 1978; 29: 161
   PubMed Web of Science ®Google Scholar
• Anderson D. W. HDL cholesterol : the variable components. Lancet 1978; i: 819
   Google Scholar
• Brewer H. B., Lux S. E., Ronan R., John K. M. Amino acid sequence of human apoLp-Gln-ll (apo A-ll). an apolipoprotein isolated from the high density lipoprotein complex. Proc. Natl. Acad. Set. U.S.A. 1972; 69: 1304
   PubMed Web of Science ®Google Scholar
• Baker H. N., Delahunty T., Gotoo A. M., Jackson R. The primary structure of high density and apolipoprotein glutamine-1. Proc. Natl. Acad. Sci. U.S.A. 1974; 3631: 71
   Google Scholar
• Levy R. I., Fredrickson D. S. Heterogeneity of plasma high density lipoproteins. J. Clin. Invest. 1965; 44: 426
   PubMed Web of Science ®Google Scholar
• Albers J. J., Aladjem F. Precipitation of1251-labelled lipoproteins with specific polypeptide antisera : evidence for two populations with differing polypeptide compositions in human high density lipoproteins. Biochemistry 1971; 3436: 10
   Google Scholar
• Nichols A. V., Lux S. E., Forte T., Gong E., Levy R. I. Degradation products from human serum high density lipoproteins following dehydration by rotary evaporation and solubilization. Biochim. Biophys. Acta. 1972; 270: 132
   PubMed Web of Science ®Google Scholar
• Fainaru M., Glangeaud M. C., Eisenberg S. Radioimmunoassay of human high density lipoprotein apoprotein A-I. Biochim. Biophys. Acta 1975; 386: 432
   PubMed Web of Science ®Google Scholar
• Fielding C. J., Shore V., Fielding P. E. A protein cofactor for lecithin : cholesterol aeyltransferase. Biochem. Biophys. Res. Commun. 1972; 46: 1493
   PubMed Web of Science ®Google Scholar
• Small D. M. Bile salts in the blood : high density lipoprotein systems and cholesterol removal. Liver and Bile. Folk Symposium 23, L. Bianchi, W. Gerok, K. Sickinger. M.T.P. Press, Lancaster 1977; 89
   Google Scholar
• Assman G., Brewer H.B. Lipid-protein interactions in high density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 1974; 71: 989
   PubMed Web of Science ®Google Scholar
• Durrington P. N., Bollon C. H., Hartog M. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinaemia. Clin. Chim. Acta. 1978; 82: 151
   PubMed Web of Science ®Google Scholar
• Albers J. J., Wahl P. W., Cabona V. G., Hazzard W. R., Hoover J. J. Quantitation of apolipoprotein A-I of human plasma high density lipoprotein. Metabolism 1976; 25: 633
   PubMed Web of Science ®Google Scholar
• Karlin J. B., Juhn D. J., Starr J. I., Scanu A. M., Rubinstein A. H. Measurement of human high density lipoprotein apolipoprotein Al in serum by radioimmunoassay. J. Lipid Res. 1976; 17: 30
   PubMed Web of Science ®Google Scholar
• Miller J. P., Mao S. J. T., Patsch J. R., Gotto A. M. The measurement of apolipoprotein A-I in human plasma by electroimmunoassay. J. Lipid Res. 1980; 21: 775
   PubMed Web of Science ®Google Scholar
• Schonfeld G., Pfleger B. The structure of human high density lipoprotein and the levels of apolipoprotein A-l in plasma as determined by radioimmunoassay. J. Clin. Invest. 1974; 54: 236
   PubMed Web of Science ®Google Scholar
• Shepherd J., Packard C. J., Patsch J. R., Gotto A. M., Taunton O. D. Metabolism of apolipoproteins A-l and A-ll and its influence on the high density lipoprotein subfraction distribution in males and females. Eur. J. Clin. Invest. 1978; 8: 115
   PubMed Web of Science ®Google Scholar
• Caslake M. J., Farish E., Shepherd J. Metabolism of apolipoprotein A-I in healthy young adults. Metabolism 1978; 437: 27
   Google Scholar
• Cheung M. C, Albers J. J. The measurement of apolipoprotein A I and A II levels in men and women by immunoassay. J. Clin. Invest. 1977; 60: 43
   PubMed Web of Science ®Google Scholar
• Schonfeld G., Bailey A., Steelman R. Plasma, apolipoprotein A-I and A-II levels in hyperlipidaemia. Lipids 1978; 951: 13
   Google Scholar
• Albers J. J., Cheung M. C, Hazzard W. R. High density lipoproteins in myocardial infarction survivors. Metabolism 1978; 479: 27
   Google Scholar
• Shepherd J., Packard C. J., Gotto A. M., Taunton O. D. A comparison of two methods to investigate the metabolism of human apolipoproteins A-l and A-II. J. Lipid Res. 1978; 19: 656
   PubMed Web of Science ®Google Scholar
• Shepherd J., Packard C. J., Morgan H. G., Third J. L.H. C, Stewart J. M., Lawrie T. D. V. The effects of cholestyramine on high density lipoprotein metabolism. Atherosclerosis 1979; 33: 433
   PubMed Web of Science ®Google Scholar
• Kostner G. M., Patsch J. R., Sailer S., Braunsteiner H., Holasek A. Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultraccntrifugation. Eur. J. Biochem. 1974; 15: 611
   Google Scholar
• Cheung M. C., Albers J. J. Distribution of cholesterol and apolipoprotein A-I and A-ll in human high density lipoprotein subfractions separated by CsCI equilibrium gradient centrifugation; evidence for HDL subpopulations with differing A-I/ A-ll molar ratios. J. Lipid Res. 1979; 20: 200
   PubMed Web of Science ®Google Scholar
• Patsch W., Schonfeld G., Gotto A. M., Patsch J. R. Characterization of human high density lipoproteins by zonal ultracentrifugation. J. Biol. Chem. 1980; 255: 3178
   PubMed Web of Science ®Google Scholar
• Weisgraber K. H., Mahley R. W. Apoprotein (E-A II) complex of human plasma lipoproteins. I. A characterization of this mixed disulfide and its identification in a high density lipoprotein subfraction. J. Biol. Chem. 1978; 253: 6281
   PubMed Web of Science ®Google Scholar
• Mahley R. W., Innerarity T. L., Bersot T. P., Lipson A., Margolis S. Alterations in human high-density lipoproteins with or without increased plasma cholesterol, induced by diets high in cholesterol. Lancet 1978; 2: 807
   PubMed Web of Science ®Google Scholar
• Hamilton R. L., Williams M. C, Fielding C. J., Havel R. J. Discoidal bilayer structure of nascent high density lipoproteins from perfused rat liver. J. Clin. Invest. 1976; 58: 677
   Web of Science ®Google Scholar
• Pottenger L. A., Getz G. S. Serum lipoprotein accumulation in the livers of orotic acid-fed rats. J. Lipid Res. 1971; 12: 450
   PubMed Web of Science ®Google Scholar
• Utermann G., Menzel H. J., Langer K. H. On the polypeptide composition of an abnormal high density lipoprotein (L.P-E) occurring in LCAT-deficient plasma. FEBS Lett. 1974; 45: 29
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D., Albers J. J., Saunders D. R., Fainaru M. Apoprotein synthesis by human duodenojejunal mucosa. Gastroenterology 1978; 75: 677
   PubMed Web of Science ®Google Scholar
• Patsch J. R., Gotto A. M., Olivecrona T., Eisenberg S. Formation of high density lipoprotein;-like particles during lipoysis of very low density lipoproteins in vitro. Proc. Natl. Acad. Sci. U.S.A. 1978; 75: 4519
   PubMed Web of Science ®Google Scholar
• Schmitz G., Assmann G. Role of LCAT in HDI3/ HDL2interconversion. Biochem. Soc. Trans. 1981; 9: I86P
   Google Scholar
• Stein Y., Glangeaud M. C, Fainaru M., Stein O. The removal of cholesterol from aortic smooth muscle cells in culture and Landschutz ascites cells by fractions of human high-density apolipoprotein. Biochem. Biophys. Acta 1975; 380: 106
   PubMed Web of Science ®Google Scholar
• Guertler L. S., Daniels R. J. Acceptor-dependency of the rate of net cholesterol efflux from human skin fibroblasts. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1980; 39: 1717
   Google Scholar
• Daniels R. J., Guertler L. S., Steinberg D. Personal communication
   Google Scholar
• ReichI D, Rudra D. N., Pflug J. The distribution of cholesterol and apolipoprotein AI among high density lipoproteins of human peripheral lymph. Biochem. Soc. Trans. 1981; 9: 212P
   PubMedGoogle Scholar
• Anderson D. W., Schaefer E. J., Bronzert T. J., Lindgren F. T., Forte T., Starzl T. E., Niblack G. D., Zech L. A., Brewer H. B. Transport of apolipoproteins A-I and A-ll by human thoracic duct lymph. J. Clin. Invest. 1981; 857: 67
   Google Scholar
• Baggio G., Fellin R., Baiocchi M. R., Martini S., Baldo C, Manzato E., Crepaldi G. Relationship between triglyceride-rich lipoprotein (chylomicrons and VLDL)and HDL; and HDLi in the postprandial phase in humans. Atherosclerosis. 1980; 37: 271
   PubMed Web of Science ®Google Scholar
• Nestel P. J., Miller N. E. Mobilization of adipose tissue cholesterol in high density lipoprotein during weight reduction in man. High Density Lipoproteins and Atherosclerosis, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier/ North Holland, Amsterdam 1978; 51
   Google Scholar
• Reich D., Myant N. B., Rudra D. N., Pflug J. J. Evidence for the presence of tissue-free cholesterol in low density and high density lipoproteins of human peripheral lymph. Atherosclerosis 1980; 489: 37
   Google Scholar
• Blum C. B., Levy R. I., Eisenberg S., Hall M., Goebel R. H., Berman M. High density lipoprotein metabolism in man. J. Clin. Invest. 1977; 60: 795
   PubMed Web of Science ®Google Scholar
• Kuusi T., Saarinen P., Nikkil'a E. A. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein; in man. Atherosclerosis 1980; 36: 589
   PubMed Web of Science ®Google Scholar
• Cooper A. D. The metabolism of chylomicron remnants by isolated perfused rat liver. Biochim. Biophys.Acta. 1997; 488: 464
   Google Scholar
• Floren C-H., Nilson A. Uptake and degradation of iodine labeled chylomicron remnant panicles by rat hepatocyte monolayers. Biochem. J. 1978; 174: 827
   PubMed Web of Science ®Google Scholar
• Shelburne F, Hanks J., Meyers W., Quarfordt S. Effect of apoproteins on hepatic uptake of triglyceride emulsions in the rat. J. Clin. Invest. 1980; 65: 652
   PubMed Web of Science ®Google Scholar
• R-Quintao E. C., Drewiaki A., Stechhalrn K., de Faria E. C, Sipahi A. M. Origin of cholesterol transported in intestinal lymph: studies with patients with filarial chyluria. J. Liphl Res. 1980; 941: 20
   Google Scholar
• Retchl D., Simons L. A., B-Myant N., Pflug J. J., Mills G. L. The lipids and lipoproteins of human peripheral lymph, with observations on the transport of cholesterol from plasma and tissues into lymph. Clin. Sci. Mol. Med. 1973; 45: 313
   PubMedGoogle Scholar
• Phillips N., Chen G. C. Radioimmunoassay of human arginine-rich apohpoprotein apoprotein E. Concentration of blood plasma and lipoproteins as affected by apoprotein E-3 deficiency. J. Clin. Invest. 1980; 66: 1351
   PubMed Web of Science ®Google Scholar
• Weidman S. W., Suarez B., M-Falko J., Kolar J. L., Witztum J., Raben M., Schonfeld G. Type III hyperlipoproteinaemia: devclopmen of a VLDL Apo E gel isoelectric focusing technique and application in family studies. J. Lab. Clin. Med. 1979; 93: 549
   PubMed Web of Science ®Google Scholar
• Barter P. J. Production of plasma esterified cholesterol in lean, normotriglyceridaemic humans. J. Lipid Res. 1974; 15: 234
   PubMed Web of Science ®Google Scholar
• L-Marcel Y., Vezina C, Teng B., Sniderman A. Transfer of cholesterol esters between human high density lipoproteins and triglyceride-rich lipoproteins controlled by a plasma protein factor. Atherosclerosis. 1980; 127: 35
   Google Scholar
• Hopkins G. T., Barter P. J. Transfers of esterified cholesterol and triglyceride between high density and very low density lipoproteins: in vitro studies of rabbits and humans. Metabolism 1980; 29: 546
   PubMed Web of Science ®Google Scholar
• Erkelens D. L., Brunzell J. D., Bierman E. L. Availability of apohpoprotein C II in relation to the maximal removal capacity for an infused triglyceride emulsion in man. Metabolism 1979; 28: 495
   PubMed Web of Science ®Google Scholar
• Stone M. C., Thorp J. M. A new technique for the investigation of the low-density lipoprotein in health and disease. Clin. Chim. Acta 1966; 14: 812
   Web of Science ®Google Scholar
• E-Miller N., Weinstein D. B., Steinberg D. and Binding, internalization, and degradation of high density lipoprotein by cultured normal human fibroblasts. J. Lipid Res. 1977; 18: 438
   PubMed Web of Science ®Google Scholar
• Miller N. E., Weinstein D. B., Carew T. E., Koschinsky T., Steinberg D. Interaction between high density and low density lipoproteins during uptake and degradation by cultured human fibroblasts. J. Clin. Invest. 1977; 60: 78
   PubMed Web of Science ®Google Scholar
• Koschinsky T., Carew T. E., Steinberg D. A comparative study of surface binding of human low density and high density lipoproteins to human fibroblasts: regulation by sterols and susceptibility to proteolytic digestion. J. Lipid Res. 1977; 18: 451
   PubMed Web of Science ®Google Scholar
• Miller N. E., Weinstein D. B., Steinberg D. Uptake and degradation of high density lipoprotein: composition of fibroblasts from normal subjects and from homozygous familial hypercholesterolaemic subjects. J. Lipid Res. 1978; 19: 644
   PubMed Web of Science ®Google Scholar
• Reckless J. P. D., Weinstein D. B., Steinberg D. Lipoprotein and cholesterol metabolism in rabbit arterial endothelial cells in culture. Biochim. Biophys. Acta 1978; 529: 475
   PubMed Web of Science ®Google Scholar
• Brown M. S., T-Kovanen P., Goldstein J. L. Evolution of the LDL receptor concept from cultured cells to intact animals. Ann. N. Y. Acad. Sci. 1980; 348: 48
   PubMedGoogle Scholar
• Steinberg D. Origin, turnover and fate of plasma low-density lipoprotein. Prog. Biochem. Pharmacol. 1979; 15: 166
   PubMedGoogle Scholar
• Nakai T., Whayne T. F. Catabolism of canine apohpoprotein A-l: purification, catabolic rate organs of catabolism, and the liver subcellular catabolic site. J. Lab. Clin. Med. 1976; 88: 63
   PubMed Web of Science ®Google Scholar
• Zech L. A., Schaefer E. J., Brewer H. B. Metabolism of plasma apolipoprotcins A-l and A-11 in man. Circulation 1978; 58: 11–40
   Web of Science ®Google Scholar
• Shepherd J., Gotto A. M., Taunton O. D., Caslake M. J., Farish E. The in vitro interaction of human apolipoprotein A-l and high density lipoproteins. Biochim. Biophys. Acta 1977; 489: 486
   PubMed Web of Science ®Google Scholar
• Sniderman A., Thomas D., Marpole D., Teng B. A metabolic pathway for return of cholesterol to the splanchnic bed. J. Clin. Invest. 1978; 61: 867
   PubMed Web of Science ®Google Scholar
• Carew T. E., Saik R. P., Johansen K. H., Dennis C. A., Steinberg D. Low density and high density lipoprotein turnover following portacaval shunt in swine. J. Lipid Res. 1976; 17: 441
   PubMed Web of Science ®Google Scholar
• Kostner G. M., Avogaro P., Cazzolato G., Marth E., Bittolo-Bon G., Quinci G. B. Lipoprotein Lp(a) and the risk of myocardial infarction. Atherosclerosis 1981; 51: 38
   Google Scholar
• Carlson K. Lipoprotein fractionation. J. Clin. Path. 1973; 26(Suppl. 5)32
   PubMed Web of Science ®Google Scholar
• Chervenka C. H. The air-driven ultracentrifuge. A rediscovered wonder. Fractions, I. 1, Palo Alto, California, 1980. Spinco Division of Beckman Instruments Inc., published by
   Google Scholar
• Jenny R. W., Newman H. A. I., Saat Y. A. A new method for the quantitation of a-Iipoprotein cholesterol. Clin. Chem. 1978; 24: 1025
   Web of Science ®Google Scholar
• Bronzert T. J., Brewer H. B. New method for measuring cholesterol in plasma lipoprotein fractions. Clin. Chem. 1981; 114: 225
   Google Scholar
• Eyre J., Hammett F., Miller N. E. A micro-method for the rapid ultracentrifugal separation of human plasma high density lipoprotein subfractions, HDL2and HDL. Clin. Chitn. Acta., In press.
   Google Scholar
• Burstein M., Scholnick H. R., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 1970; 11: 583
   PubMed Web of Science ®Google Scholar
• Mahley R. W., Innerarity T. L. Interaction of canine and swine lipoproteins with the low density lipoprotein receptor of fibroblasts as correlated with heparin manganese precipitability. J. Biol. Chem. 1977; 252: 3980
   PubMed Web of Science ®Google Scholar
• Shelburne F. H., Quarfordt S. H. The interaction of heparin with an apoprotein of human very low density lipoprotein. J. Clin. Invest. 1977; 60: 944
   PubMed Web of Science ®Google Scholar
• Innerarity T. L., Mahley R. W., Weisgraber K. H., Bersot T. P. Apoprotein (E-A II) complex of human plasma lipoproteins. II Receptor binding activity of high density lipoprotein subfraction modulated by the apo (E-A 11) complex. J. Biol. Chem. 1978; 253: 6287
   Web of Science ®Google Scholar
• Warnick G. R., Albers J. J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J. Lipid Res. 1978; 19: 65
   PubMed Web of Science ®Google Scholar
• Albers J. J., Warnick G. R., Cheung M. C. Quantitation of high density lipoproteins. Lipids 1978; 926: 13
   Google Scholar
• Albers J. J., Warnick G. R., Wiebe D., King P., Steiner P., Smith L., Breckenridge C, Chow A., Kuba K., Weidman S., Arnett H., Wood P., Shlagenhaft A. Multi-laboratory comparison of three heparin-Mn2+precipitation procedures for estimating cholesterol in high-density lipoprotein. Clin. Chem. 1978; 24: 953
   Web of Science ®Google Scholar
• Majfield C, Warnick G. R., Albers J. J. Evaluation of commercial heparin preparations for use in the heparin-Mn2 method for measuring cholesterol in high-density lipoproteins. Clin. Chem. 1979; 25: 1309
   PubMed Web of Science ®Google Scholar
• Steele B. W., Koehler D. F., Azar M. M., Blaszkowski T. P., Kuba K., Dempsey M. E. Enzymatic determinations of cholesterol in high-density-lipoprotein fractions prepared by a precipitation technique. Clin. Chem. 1976; 22: 98
   PubMed Web of Science ®Google Scholar
• Durrington P. N. A comparison of three methods of measuring serum high density lipoprotein cholesterol in diabetics and non-diabetics. Ann. Clin. Biochem. 1980; 17: 199
   PubMed Web of Science ®Google Scholar
• Albers J. J., Warrick R., Johnson N., Bachorik P. S., Mussing R., Lippel K., Williams O. D. Quality control of plasma high-density lipoprotein cholesterol methods. Lipid Res. Clin. Program Prevalence Study dr. 1980; 62(Suppl IV)9
   Google Scholar
• Cornwall D. G., Kruger F. A. Molecular complexes in the isolation and chacterization of plasma lipoproteins. J Lipid Res. 1961; 2: 110
   PubMed Web of Science ®Google Scholar
• Warnick G. R., Albers J. J. Heparin-Mn2+quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin. Chem. 1978; 24: 900
   PubMed Web of Science ®Google Scholar
• Lopes-Virella M. F., Stone P., Ellis S., Colwell J. A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin. Chem. 1977; 23: 882
   PubMed Web of Science ®Google Scholar
• Demacker P. N. M., Vos-Janssen H. E., Hijmans A. G. M., Jansen A. P. Measurement of high-density lipoprotein cholesterol in serum: comparison of six isolation methods combined with enzymic cholesterol analysis. Clin. Chem. 1980; 26: 1780
   PubMed Web of Science ®Google Scholar
• Viikari J. Precipitations of plasma lipoproteins by PEG-6000 and its evaluation with electrophoresis and ultracentrifugation. Scand. J. Clin. Lab. Invest. 1976; 36: 265
   PubMed Web of Science ®Google Scholar
• Demacker P. N. M., Hijmans A. G. M., Vos-Janssen H. E., van't Laar A., Jansen A. P. A study of the use of polyethylene glycol in estimating cholesterol in high-density lipoprotein. Clin. Chem. 1980; 26: 1775
   PubMed Web of Science ®Google Scholar
• Izzo C, Crillo F., Murador E. Improved method for determination of high-density-lipoprotein cholesterol. I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. Clin. Chem. 1981; 371: 27
   Google Scholar
• Khan S. R., Elkeles R. S., Niththyananthan R., Seed M., Wynn V. Analysis of high density lipoprotein subclasses by a precipitation procedure: comparison with preparative ultracentrifugation. Clin. Chim. Acta 1982; 120: 49
   PubMed Web of Science ®Google Scholar
• Wilson D. E., Spiger M. J., Done G. A. A dual precipitation method for quantitative plasma lipoprotein measurement without ultracentrifugation. J. Lab. Clin. Med. 1973; 82: 473
   PubMed Web of Science ®Google Scholar
• Gidez L. I., Miller G. J., Burstein Mand, Eder H. A. in Report of the High Density Lipoprotein Methodology Workshop. U.S. Department of Health, Education and Welfare, K. Lippel. N.l.H. Publication No. 79-1661. 1979; 310
   Google Scholar
• Srinivasan S. R. Radhakrishnamurthy Band Berenson, G. S., Studies on the interaction of heparin with serum lipoproteins in the presence of Ca2+Mg2+and Mn2+. Arch. Biochem. Biophys. 1975; 334: 170
   Google Scholar
• Milch L. J., Weiner N., Robinson L. G. Variability studies of the flotation technique of analytical ultracentrifugation. J. Phys. Chem. 1955; 59: 948
   Web of Science ®Google Scholar
• Del Gatto L., Nichols A. V., Lindgren F. T. Effects of freeze-lhawing and storage, on ultracentrifugal properties of human serum lipoproteins. Proc. Soc. Exp. Biol. Med. 1959; 101: 59
   PubMed Web of Science ®Google Scholar
• Bachorik P. S., Wood P. D., Albers J. J., Steiner P., Dempsey M., Kuba K., Warnick R., Karlsson L. Plasma high-density lipoprotein cholesterol concentrations determined after removal of other lipoproteins by heparin/manganese precipitation or by ultracentrifugaiion. Clin. Chem. 1976; 22: 1828
   PubMed Web of Science ®Google Scholar
• Reckless J. P. D., Betteridge D. J., Wu P., Payne B., Galton D. J. Effect of storage on plasma lipoproteins. Lancet 1977; 2: 350
   PubMed Web of Science ®Google Scholar
• Helgoland A., Hjerman I., Leren P., Enger S., Holme I. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo Study. Br. Med. J. 1978; 2: 403
   PubMed Web of Science ®Google Scholar
• Warnick G. R., Mayfield C., Albers J. J. Evaluation of quality-control materials for high-density-lipoprotein cholesterol quantitation. Clin. Chem. 1981; 27: I–16
   Web of Science ®Google Scholar
• Zak B. Cholesterol methodologies: a review. Clin. Chem. 1977; 23: 1201
   PubMed Web of Science ®Google Scholar
• Allain C. C, Poon L. S., Chan C. S. G., Richmond W., Fu P. C. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974; 20: 470
   PubMed Web of Science ®Google Scholar
• Jung D. H., Biggs H. G., Moorhead W. R. Colorimetry of serum cholesterol with use of ferric acetate/ uranyl acetate and ferrous sulfate/sulfuric acid reagents. Clin. Chem. 1975; 21: 1526
   PubMed Web of Science ®Google Scholar
• Patsch J. R., Sailor S., Kostner G., Sandhofer F., Holasek A., Braunsteiner H. Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation. J. Lipid Res. 1974; 356: 15
   Google Scholar
• Havel R. J., Eder H. A., Bragdon J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955; 34: 1345
   PubMed Web of Science ®Google Scholar
• Mahley R. W, Hui D. Y., Inmerarity T. L., Weisgraber K. H. Two independent lipoprotein receptors on hepathe membranes of dog, swine, and man. Apo-B, E and apo-E receptors. J. Clin. Invest. 1981; 68: 1197
   PubMed Web of Science ®Google Scholar
• Terebus-Kekish O., Barclay M., Stock C. C. Discrete separation of HDL, from HDLi of human serum by means of polyacrylamide gel. Clin. Chim. Acta 1978; 88: 9
   PubMed Web of Science ®Google Scholar
• Ishikawa T. T., Brazier J. B., Steiner P. M., Stewart L. E., Gartside P. S., Glueck C. J. A study of the heparin-manganese chloride method for determination of plasma a-lipoprotein cholesterol concentration. Lipids 1976; 11: 628
   PubMed Web of Science ®Google Scholar
• Danner S. A., De Beaumont M-J., Dunning A. J. Cardiovascular health in the tenth decade. Br. Med. J. 1978; 2: 663
   PubMed Web of Science ®Google Scholar
• Carlson L. A., Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Studies in healthy men and women. Atherosclerosis 1975; 21: 417
   PubMed Web of Science ®Google Scholar
• Slack J., Nobel N., Meade T. W, North W. R. S. Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London. Br. Med. J. 1977; 2: 353
   PubMed Web of Science ®Google Scholar
• Lewis B., Chait A., Sigurdsson G., Mancini M., Farinaro E., Oricute P., Carlson L. A., Ericsson M., Micheli H., Pornetta D. Serum lipoproteins in four European communities. A quantitative comparison. Eur. J. Clin. Invest. 1978; 8: 165
   PubMed Web of Science ®Google Scholar
• Tyroler H. A., Hames C. G., Krishan I., Heyden S., Cooper G., Cassel J. C. Black-white differences in serum lipids and lipoproteins in Evans County. Prev. Med. 1975; 4: 541
   PubMed Web of Science ®Google Scholar
• Srinivasan S. R., Frerichs R. R., Webber L. S., Berensen G. S. Serum lipoprotein profile in children from a biracial community: the Bogalusa Heart Study. Circulation 1976; 54: 309
   PubMed Web of Science ®Google Scholar
• Glueck C. J., Heiss G., Tyroler H. A., Christensen B., Kwiterovich P. O., de Groot I, Chase G., Mowery R., Tamir I. Black-white plasma lipoprotein differences in children. Circulation 1978; 58(suppl II)31
   Google Scholar
• Momson J. A., de Groot I., Edwards B. K., Kelly K. A., Mellies M. J., Khoury P., Glueck C. J. Lipids and lipoproteins in 927 school children, ages 6-17 years. Pediatrics 1978; 990: 62
   Google Scholar
• Tyroler H. A., Glueck C. J., Christensen B., Kwiterovich P. O. Plasma high-density lipoprotein cholesterol comparison in Black and White populations. The lipid research clinics program prevalence study. Circulation 1980; 62(suppl IV)99
   Google Scholar
• Frerichs R. P., Srinivasan S. R., Webber L. S., Reith M. C., Berensen G. S. Serum lipids and lipoproteins at birth in a biracial population. The bogalusa heart study. Pediair. Res. 1978; 12: 858
   PubMed Web of Science ®Google Scholar
• Rifkind B. M. Tamir, I., Heiss, G., Preliminary high density lipoprotein findings. The Lipid Research Clinics Program in High Density Lipoproteins and Atheroscleroris, A. M. Gotto, N.E. Miller, M. F. Oliver. Elsevier/ North Holland, New York 1978; 109
   Google Scholar
• Stanhope J. M., Sampson V. M., Clarkson P. M. High-density lipoprotein cholesterol and other serum lipids in a New Zealand biracial adolescent sample. The Wairoa College study. Lancet 1977; I: 968
   Google Scholar
• Yano Y., Irie N., Homma Y., Tsushima M., Takeuchi I., Nakaya N., Goto Y. High density lipoprotein cholesterol levels in the Japanese. Atherosclerosis. 1980; 36: 173
   PubMed Web of Science ®Google Scholar
• Williams O. D., Heiss G., Beaglehole R., Dennis B., Bazzarre T., Tyroler H. A. Hyperlipidaemia and nutrition: data base and trends. Athersclerosis Rev. 1980; 7: 145
   Google Scholar
• Walker A. R. P., Walker B. F. High high density lipoprotein cholesterol in African children and adults in a population free of coronary heart disease. Br. Med. J. 1978; 2: 1336
   PubMed Web of Science ®Google Scholar
• Bang H. O., Dyerberg J., Nielsen A. B. Plasma lipid and lipoprotein pattern in Greenlandic west-coast Eskimos. Lancet 1971; 1: 1143
   PubMed Web of Science ®Google Scholar
• Connor W. E., Cerqueira M. T., Connor R. W., Wallace R. B., Malinow M. R., Casdorph H. R. The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico. Am. J. Clin. Nutr. 1978; 31: 1131
   PubMed Web of Science ®Google Scholar
• Carlson L. A., Mossfeldt F. Acute effects of prolonged heavy exercise on the concentration of plasma lipids and lipoproteins in man. Acta Physiol. Scand. 1964; 62: 51
   PubMedGoogle Scholar
• Wood P. D., Haskell W., Klein H., Lewis S., Stern M. P., Farquahar J. W. The distribution of plasma lipoproteins in middle-aged male runners. Metabolism 1976; 25: 1249
   PubMed Web of Science ®Google Scholar
• Enger S. C, Herbjômsen K, Erikssen J., Fretland A. High density lipoproteins (HDL) and physical activity: the influence of physical exercise, age and smoking on HDL cholesterol and the HDL-/total cholesterol ratio. Scand. J. Clin. Lab. Invest. 1977; 37: 251
   PubMed Web of Science ®Google Scholar
• Wood P. D., Haskell W. L., Stern M. P., Lewis S., Perry C. Plasma lipoprotein distributions in male and female runners. Ann. N. Y. Acad. Sci. 1977; 301: 748
   PubMedGoogle Scholar
• Martin R. P., Haskell W. L., Wood P. D. Blood chemistry and lipid profiles of elite distance runners. Ann. N. Y. Acad. Sci. 1977; 301: 346
   PubMedGoogle Scholar
• Gilliam T. B., Burke M. B. Effects of exercise on serum lipids and lipoproteins in girls, aged 8-10 years. Artery 1978; 4: 203
   Google Scholar
• Lehtonen A., Viikari J. Serum triglycerides and cholesterol and serum high-density lipoprotein cholesterol in highly physically active men. Acta Med. Scand. 1978; 204: 111
   PubMedGoogle Scholar
• Williams P., Robinson D., Bailey A. High-density lipoprotein and coronary risk factors in normal men. Lancet 1979; i: 72
   Google Scholar
• Lopez-S A., Vial R., Bolart L., Arroyave G. Effects of exercise and physical fitness on serum lipids and lipoproteins. Atherosclerosis 1974; 20: I
   Web of Science ®Google Scholar
• Wood P. D., Haskell W. L. The effect of exercise on plasma high density lipoproteins. Lipids 1979; 14: 417
   PubMed Web of Science ®Google Scholar
• Vodak P. A., Wood P. D., Haskell W. L., Williams P. T. HDL-cholesteroI and other plasma lipid and lipoprotein concentrations in middle-aged male and female tennis players. Metabolism 1980; 29: 745
   PubMed Web of Science ®Google Scholar
• Haskell W. L., Taylor H. L., Wood P. D., Schrott H., Heiss G. Strenuous physical activity, treadmill exercise test performance and plasma high-density lipoprotein cholesterol. The lipid research clinics program prevalence study. Circulation 1980; 62(Suppl. IV)53
   Google Scholar
• Enger S. C, Strtimme S. B., Refsum H. E. High-density lipoprotein cholesterol, total cholesterol and triglycerides in serum after a single exposure to prolonged heavy exercise. Scand. J. Clin. Lab. Invest. 1980; 40: 341
   PubMed Web of Science ®Google Scholar
• Altekruse E. G., Wilmore J. H. Changes in blood chemistries following a controlled exercise program. J. Occup. Med. 1973; 15: 110
   PubMedGoogle Scholar
• Leon A. S., Conrad J., Hunninghake D. G., Serfass R. Effects of a vigorous walking program on body composition and carbohydrate and lipid metabolism of obese young men. Am. J. Clin. Nutr. 1979; 32: 1776
   PubMed Web of Science ®Google Scholar
• Sutherland W. H. F., Woodhouse S. P. Physical activity and plasma lipoprotein lipid concentrations in men. Atherosclerosis 1980; 37: 285
   PubMed Web of Science ®Google Scholar
• Farrell P. A., Barboriak J. The time course of alterations in plasma lipid and lipoprotein concentrations during eight weeks of endurance training. Atherosclerosis 1980; 231: 37
   Google Scholar
• Widhalm K., Maxa E., Zyman H. Effect of diet and exercise upon the cholesterol and triglyceride content of plasma lipoproteins in overweight children. Eur. J. Pediair. 1978; 127: 121
   PubMed Web of Science ®Google Scholar
• Penfold R. A., Moore W. A. F., Simpson R. D., Simpson R. W., Mann J. I., Turner R. C. High-density lipoprotein, lipid and carbohydrate metabolism during increased fitness. Ann. Clin. Biochem. 1979; 16: 76
   PubMed Web of Science ®Google Scholar
• Moll M. E., Williams R. S., Lester R. M., Quarfordt S. H., Wallace A. G. Cholesterol metabolism in non-obese women - failure of physical conditioning to alter levels of high-density lipoprotein cholesterol. Atherosclerosis. 1979; 34: 159
   PubMed Web of Science ®Google Scholar
• Nikkilä E., Kuusi T., Myllynen P. High-density lipoprotein and apolipoprotein A-I during physical activity - demonstration of low levels in patients with spine fracture. Atherosclerosis. 1980; 457: 37
   Google Scholar
• Nye E. R., Carlson K., Kirstein P., Rossner S. Changes in high-density lipoprotein subfractions and other lipoproteins induced by exercise. Clin. Chim. Ada. 1981; 113: 51
   PubMed Web of Science ®Google Scholar
• Krauss R. M., Lindgren F. T., Wood P. O., Haskell W. L., Albers J. J., Cheung M. C. Differential increases in plasma high-density lipoprotein subfractions and apolipoproteins (apo-Lp) in runners. Circulation 1977; 56(Suppl. 11)4
   Google Scholar
• Goldbourt U., Medalie J. H. Characteristics of smokers, nonsmokers and ex-smokers among 10.000 adult males in Israel. II. Physiological, biochemical and genetic characteristics. Am. J. Epidemiol. 1977; 105: 76
   Google Scholar
• Garrison R. J., Kannel W. B., Feinleib M., Castelli W. P., McNamarra P. M., Padgett S. J. Cigarette smoking and HDL cholesterol. The Framingham offspring study. Atherosclerosis 1978; 30: 17
   PubMed Web of Science ®Google Scholar
• Durrington P. N. Serum high-density lipoprotein cholesterol in diabetes mellitus: an analysis of factors which influence its concentration. Clin. Chim. Ada 1980; 104: 11
   PubMed Web of Science ®Google Scholar
• Criqui M. H., Wallace R. B., Heiss G., Mishkel M., Schonfeld C, Jones G. T. L. Cigarette smoking and plasma high-density lipoprotein cholesterol. The lipid research clinics program prevalence study. Circulation 1980; 62(Suppl. IV)70
   Google Scholar
• Hulley S. B., Cohen R., Widdowson G. Plasma high-density lipoprotein cholesterol level. Influence of risk factor intervention. JAMA 1977; 238: 2269
   PubMed Web of Science ®Google Scholar
• Ernst N., Fisher M., Smith W., Gordon T., Rifkind B. M., Little J. A., Mishkel M. A., Williams O. D. The association of plasma high-density lipoprotein cholesterol with dietary intake and alcohol consumption. The lipid research clinics program prevalence study. Circulation 1980; 62(Suppl. IV)41
   Google Scholar
• Yano K., Rhoads G. G., Kagan A. Coffeealcohol and risk of coronary heart disease among Japanese men living in Hawaii. N. Engl. J. Med. 1977; 297: 405
   PubMed Web of Science ®Google Scholar
• Castelli W. P., Doyle J. T., Gordon T., Hames C. G., Hjortland M. C., Hulley S. B., Kagan A., Zukel W. J. Alcohol and blood lipids. The cooperative lipoprotein phenotyping study. Lancet 1977; 2: 153
   PubMed Web of Science ®Google Scholar
• Belfrage P., Berg B., Hagerstand J., Nilsson-Ehle P., Tornqvist H., Wiebe T. Alteration of lipid metabolism in healthy volunteers during long-term ethanol intake. Eur. J. Clin. Invest. 1977; 7: 127
   PubMed Web of Science ®Google Scholar
• Klatsky A. L., Friedman G. D., Siegelaub A. G. Alcohol consumption before myocardial infarction. Results from the Kaiser-Permanente epidemiological study of myocardial infarction. Ann. Int. Med. 1974; 81: 294
   PubMed Web of Science ®Google Scholar
• Stason W. B., Neff R. K., Miettinen O. S., Jick H. Alcohol consumption and non-fatal myocardial infarction. Am. J. Epidemiol. 1976; 603: 104
   Google Scholar
• Marmot M. G., Rose G., Shipley M. J., Thomas B. J. Alcohol and mortality: a U-shaped curve. Lancet 1981; I: 580
   Google Scholar
• Wigfield W. J., Hill W. J. Alcohol and mortality. Lancet 1981; I: 1052
   Google Scholar
• Baraona E., Leo M. A., Borowsky S. A., Leiber C. S. Pathogenesis of alcohol-induced accumulation of protein in the liver. J. Clin. Invest. 1977; 60: 546
   PubMed Web of Science ®Google Scholar
• Chait A., Mancini M., February A. W., Lewis B. Clinical and metabolic study of alcoholic hyperlipidaemia. Lancet 1972; 2: 62
   PubMed Web of Science ®Google Scholar
• Wilson D. E., Lees R. S. Reciprocal changes in the concentrations of very low and low density lipoproteins in man. J. Clin. Invest. 1972; 51: 1051
   PubMed Web of Science ®Google Scholar
• Logan R. L., Riemersma R. A., Thomson M., Oliver M. F., Olsson A. G., Walldius G., Rossner S., Kaijser L., Callmer E., Carlson L. A., Lockerbie L., Lutz W. Risk factors for ischaemic heart-disease in normal men aged 40 - Edinburgh - Stockholm study. Lancet 1978; 1: 949
   PubMed Web of Science ®Google Scholar
• Glueck C. J., Taylor H. L., Jacobs D., Morrison J. A., Beaglehole M. D., Williams O. D. Plasma high-density lipoprotein cholesterol: association with measurements of body mass. The lipid research clinics program prevalence study. Circulation 1980; 62(Suppl. IV)62
   Google Scholar
• Contaldo F., Strazzullo P., Postiglione A., Riccardi G., Patti L., Di Biase G., Mancini M. Plasma high-density lipoprotein in severe obesity after stable weight loss. Atherosclerosis 1980; 37: 163
   PubMed Web of Science ®Google Scholar
• Shepherd J., Packard C. J., Patsch J. R., Gotto A. M., Taunton O. D. Effects of dieiary polyunsaturated and saturated fat on the properties of high-density lipoproteins and the metabolism of apolipoprotein A-l. J. Clin. Invest. 1978; 61: 1582
   PubMed Web of Science ®Google Scholar
• Nichaman M. Z., Sweeley C. C., Olson R. E. Plasma fatty acids in normolipemic and hyperlipemic subjects during fasting and after linoleate feeding. Am. J. Clin. Nutr. 1967; 20: 1057
   PubMed Web of Science ®Google Scholar
• Spritz N., Mishkel M. A. Effects of dietary fats on plasma lipids - an hypothesis for the lipid-lowering effect of unsaturated fatty acids. J. Clin. Invest. 1969; 48: 78
   PubMed Web of Science ®Google Scholar
• Farquhar J., Sokolow M. Responses of serum lipids and lipoproteins of man to beta sitosterol and safflower oil. Circulation 1958; 17: 890
   PubMed Web of Science ®Google Scholar
• Durrington P. N., Bolton C. H., Hartog M., Angelinetta K., Emmett P., Furniss S. The effect of a low-cholesterol, high-polyunsaturate diet on serum lipid levels, apolipoprotein B levels and triglyceride fatty acid composition. Atherosclerosis 1977; 27: 465
   PubMed Web of Science ®Google Scholar
• Lewis B. Effects of diets and drugs. High Density Lipoproteins, A. M. Gotto, N. E. Miller, M. F. Oliver. Elsevier - North Holland, Amsterdam 1978; 143
   Google Scholar
• Witztum J. L., Schonfeld G., Wiedman S. W., Giese W. E., Dillingham M. A. Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins. Metabolism 1979; 28: 221
   PubMed Web of Science ®Google Scholar
• Hjerman I., Enger S. C., Helgeland A., Holme I., Leren P., Trygg K. The effect of dietary changes on high-density lipoprotein cholesterol: the Oslo study. Am. J. Med. 1979; 66: 105
   PubMed Web of Science ®Google Scholar
• Schonfeld G., Weidman S. W., Witztum J. L., Bowen R. M. Alterations in levels and interrelations of plasma apolipoproteins induced by diet. Metabolism 1976; 25: 261
   PubMed Web of Science ®Google Scholar
• Dixon M. Bran and HDL-cholesterol. Br. Med. J. 1978; I: 578
   Google Scholar
• Sacks F. M., Castelli W. P., Donner A., Kass E. H. Plasma lipids and lipoproteins in vegetarians and controls. N. Engl. J. Med. 1975; 292: I–148
   Web of Science ®Google Scholar
• Burslem J., Schonfeld G., Howald M.A., Weidman S. W., Miller J. P. Plasma apoprotein and lipid levels in vegetarians. Metabolism 1978; 27: 71–I
   PubMed Web of Science ®Google Scholar
• Raymond T. L., Connor W. E., Lin D. S., Warner S., Fry M. M., Connor S. L. The interaction of dieiary fibers and cholesterol upon the plasma lipids and lipoproteins, sterol balance, and bowel function in human subjects. J. Clin. Invest. 1977; 60: 1429
   PubMed Web of Science ®Google Scholar
• Nichols A. V. Human serum lipoproteins and their interrelationships. Adv. Biol. Med. Phys. 1967; 110: 11
   Google Scholar
• Davis C. E., Gordon D., La Rosa J., Wood P.D.S., Halperin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations. The lipid research clinics program prevalence study. Circulation 1980; 62(Suppl. IV)24
   Google Scholar
• Krause R. M., Lindgren F. T., Ray R. M. Interrelationships among subgroups of serum lipoproteins in normal human subjects. Clin. Chim. Acta 1980; 104: 275
   PubMed Web of Science ®Google Scholar
• Schaefer E. J., Levy R. I., Anderson D. W., Danner R. N., Brewer H. B., Blackwelder W. C. Plasma-triglycerides in regulation of HDL-cholesterol levels. Lancet 1978; 2: 391
   PubMed Web of Science ®Google Scholar
• Fredrickson D. S., Goldstein J. L., Brown M. S. Familial hyperlipoproteinaemias. Metabolic Basis of Inherited Disease,4th ed., Stanbury, J. B. Wyngaarden, D. S. Fredrickson. McGrawHill, New York 1978; 608
   Google Scholar
• Kekki M. Lipoprotein-lipase action determining plasma high-density lipoprotein cholesterol level in adult normolipaemics. Atherosclerosis. 1980; 37: 143
   PubMed Web of Science ®Google Scholar
• Rao S. N., Magill P. J., Miller N. E., Lewis B. Plasma high-density lipoprotein metabolism in subjects with primary hypertriglyceridaemia: altered metabolism of apoproteins Al and All. Clin. ScL 1980; 59: 359
   PubMed Web of Science ®Google Scholar
• Witztum J. L., Dillingham M., Giese W., Schonfeld G., Weidman S. Normalization of triglycerides in type IV hyperlipoproteinaemia fails to correct low HDL-cholesterol values. Clin. Res. 1977; 25: 569A
   Google Scholar
• Carlson L. A., Olsson A. G., Ballantyne D. On the rise in low-density and high-density lipoprotein in response to the treatment of hypertriglyceridaemia in type IV and type V hyperlipoproteinaemias. Atherosclerosis. 1977; 603: 26
   Google Scholar
• Glueck C. J., Stein E. A., Kashyop M. L., Steiner P. M. Persistent hypoalphalipoproteinaemia during therapy of familial type V hyperlipoproteinaemia. Clin. Res. 1978; 26: 680
   Google Scholar
• Hulley S. B., Rosenman R. H., Bawol R. D., Brand R. J. Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart diseases. N. Engl. J. Med. 1980; 302: 1383
   PubMed Web of Science ®Google Scholar
• Falko Witztum J. M., Schonfeld J. L., Weidman S. W., Kolar J. B. Type III hyperlipoproteinaemia: rise in high-density lipoprotein levels in response to therapy. Am. J. Med. 1979; 303: 66
   Google Scholar
• Streja D., Steiner G., Kwiterovich P. O. Plasma high-density lipoproteins and ischaemic heart disease. Studies in a large kindred with familial hypercholesterolaemia. Ann. Int. Med. 1978; 89: 871
   PubMed Web of Science ®Google Scholar
• Herbert P. N., Gotto A. M., Fredrickson D. S. Familial lipoprotein deficiency (Abelalipopro-teinaemia, Hypobetalipoproteinaemia and Tangier Disease). The Metabolic Basis of Inherited Disease, Stanbury, J. B. Wyngaarden, D. S. Fredrickson. McGraw-Hill, New York 1978
   Google Scholar
• Assman G., Smootz E. High-density lipoprotein infusion and partial plasma exchange in Tangier disease. Eur. J. Clin. Invest. 1978; 8: 131
   PubMed Web of Science ®Google Scholar
• Glueck C. J., Fallal R. W., Millet F., Steiner P. M. Familial hyperalphalipoprotcinaemia. Arch. Int. Med. 1975; 135: 1025
   PubMedGoogle Scholar
• Glueck C. J., Gartside P., Fallat R. W., Sielski J., Steiner P. M. Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinaemia. J. Lab. Clin. Med. 1976; 88: 941
   PubMed Web of Science ®Google Scholar
• Committee of Principal Investigators. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate. Br. Heart J… 1978; 40: 1069
   PubMedGoogle Scholar
• Steinberg D., Grundy S. M. Management of hyperlipidaemia. Diet and drugs. Arch. Surg. 1978; 113: 55
   PubMedGoogle Scholar
• Shepherd J., Packhard C. J., Bicker S., Lawrie T. D. V., Morgan H. G. Cholestyramine promotes receptor-mediated low-density-lipoprotein metabolism. N. Engl. J. Med. 1980; 302: 1219
   PubMed Web of Science ®Google Scholar
• Illingworth D. R., Phillipson B. E., Rapp J. H., Connor W. E. Colestipol plus nicotinic acid in treatment of heterozygous familial hypercholesterolaemia. Lancet 1981; 1: 296
   PubMed Web of Science ®Google Scholar
• Kane J. P., Malloy M. J., Tun P., Phillips N. R., Freedman D. D., Williams M. L., Rowe J. S., Havel R. J. Normalisation of low-density-lipoprotein levels in heterozygous familial hypercholesterolaemia with a combined drug regimen. N. Engl. J. Med. 198; 304: 251
   Google Scholar
• Pattnaik N. M., Zilversmit D. B. Effect of size and competition by lipoproteins and apolipoproteins on the uptake of chylomicrons and chylomicron remnants by hepatoma cells in culture. Biochim. Biophys. Ada 1980; 617: 335
   PubMed Web of Science ®Google Scholar
• Witztum J. L., Schonfeld G., Weidman S. W., Geese W. E., Dillingham M. A. Bile sequestrant therapy alters the composition of low-density and high-density lipoproteins. Metabolism 1979; 28: 221
   PubMed Web of Science ®Google Scholar
• Spengel F., Soutar A. K., Duffield R., Wood C, Thompson G. R. Low density lipoprotein (LDL) metabolism after cholestyramine and ileal bypass in familial hypercholesterolaemia (FH). Eur. J. Clin. Invest. 1981; I(Suppl 2)30
   Google Scholar
• Moore R. B., Varco R. L., Buchwald H. Effect of partial ileal bypass on plasma lipoproteins. Am. J. Cardiol. 1978; 41: 404
   Web of Science ®Google Scholar
• Berger G. M. B., Miller J. L., Bonnici F., Joffe H. S., Dubovsky D. W. Continuous flow plasma exchange in the treatment of homozygous familial hypercholesterolaemia. Am. J. Med. 1978; 65: 243
   PubMed Web of Science ®Google Scholar
• Thompson G. R., Lowenthal R., Myant N. B. Plasma exchange in the management of homozygous familial hypercholesterolaemia. Lancet 1975; I: 1208
   Google Scholar
• Shepherd J., Packard C. J., Patsch J. K., Gotto A. M., Taunton O. D. Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. J. Clin. Invest. 1979; 63: 858
   PubMed Web of Science ®Google Scholar
• Grundy S. M, Ahrens E. H., Salen G., Schreibman Ph.H., Nestel P. J. Mechanisms of action of clofibrate on cholesterol metabolism in patients with hyperlipidaemia. J. Lipid Res. 1972; 13: 531
   PubMed Web of Science ®Google Scholar
• Patsch J. R., Yeshuran D., Jackson R. L., Gotto A. M. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type 111 hyperlipoproteinaemia. Am. J. Med., hi. 1977; 1001
   Google Scholar
• Brook J. G., Lavy A., Aviram M., Zinder O. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinaemia and the effect of clofibrate. Atherosclerosis 1980; 461: 36
   Google Scholar
• Crouse J. R., Grundy S. M. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolaemia. Metabolism 1981; 30: 123
   PubMed Web of Science ®Google Scholar
• Cheung M. C, Albers J. J., Wahl P. W., Hazzard W. R. High density lipoproteins during hypolipidemic therapy. A comparative study of four drugs. Atherosclerosis 1980; 215: 35
   Google Scholar
• Le Lorier J., Du Breuill-Quidoz S., Lussier-Cacan S, Huang Y. S., Davignon J. Diet and probucol in lowering cholesterol concentrations. Arch. Intern. Med. 1977; 137: 1429
   PubMedGoogle Scholar
• Mellies M. J., Gartside P. S., Glatfelter L., Vink P., Guy G., Schonfeld G., Glueck C. Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins Al and A2 in adults with primary familial hypercholesterolaemia. Metabolism 1980; 29: 956
   PubMed Web of Science ®Google Scholar
• Riesen W. F., Keller M., Mordasini R. Probucol in hypercholesterolaemia. Atherosclerosis. 1980; 36: 201
   PubMed Web of Science ®Google Scholar
• Bateson M. C. Probucol with cholestyramine. Lancet 1981; 2: 93
   PubMed Web of Science ®Google Scholar
• Miettinen T. A., Huttunen J. K., Ehnholm C, Kumlin T., Mattila S., Naukkarinen V. Effect of long-term antihypertensive and hypolipidaemic treatment on high-density lipoprotein cholesterol and apolipoprotein A-l and A-Il. Atherosclerosis 1981; 36: 249
   Google Scholar
• Bateson M. C, Fiabane A. M., Clarke A., Bouchier I. A. D. Probucol and hypercholesterolaemia. Br. J. Pharmacol 1981; II: 531
   Google Scholar
• Miettinen T. A., Huttunen J. K., Kuusi T., Kumlin T., Mattila S., Naukkarinen V., Strandberg T. Effect of probucol on the activity of postheparin lipoprotein lipase and hepatic lipase. Clin. Chim. Acta 1981; 113: 59
   PubMed Web of Science ®Google Scholar
• Nestel P. J., Billington T. Effects of probucol on low density lipoprotein removal and high density lipoprotein synthesis. Atherosclerosis 1981; 38: 203
   PubMed Web of Science ®Google Scholar
• Magill P., Whiting C, Hammet F., Click I., Miller N., Lewis B. Probucol effects on metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia. 7th Int. Symp. Drugs Affecting Lipid Metab. 1980; 94
   Google Scholar
• Tanaka N., Sakaguchi S., Oshige K., Niimura T., Kanchisa T. Effect of chronic administration of propranolol on lipoprotein composition. Metabolism 1976; 25: 1071
   PubMed Web of Science ®Google Scholar
• Shaw J., England J. D. F., Hua A. S. P. Betablockers and plasma triglycerides. Br. Med. J. 1978; 1: 986
   PubMed Web of Science ®Google Scholar
• Day J. L., Simpson N., Metcalfe J., Page R. L. Metabolic consequences of atenolol and propranolol in treatment of hypertension. Br. Med. J. 1979; 1: 77
   PubMed Web of Science ®Google Scholar
• Lehtonen A., Viikari J. Long-term effect of sotalol on plasma lipids. Clin. Sci. 1979; 57(Suppl. 5)405S
   Google Scholar
• Wallace R. B., Hunninghake D. B., Reiland S., Barrett-Connor E., Mackenthun A., Hoover J., Wahl P. Alterations of plasma high-density lipoprotein cholesterol levels associated with consumption of selected medications. The lipid research clinics program prevalence study. Circulation 1980; 62(Suppl. IV)77
   Google Scholar
• Nilsson A., Hansson B-G., Mokfelt B. Betablockers and lipid metabolism. Br. Med. J. 1977; 2: 126
   PubMed Web of Science ®Google Scholar
• Sleight P. Beta-adrenergic blockade after myocardial infarction. N. Engl. J. Med. 1981; 304: 837
   PubMed Web of Science ®Google Scholar
• Editorial. Antihypertensive drugs, plasma lipids and coronary disease. Lancet 1980; 19: 2
   Google Scholar
• Barr D. P. Influence of sex and sex hormones upon the development of athersclerosis and upon the lipoproteins of plasma. J. Chronic Dis. 1955; 1: 63
   PubMedGoogle Scholar
• Stamler J., Katz L. N., Pick R., Lewis L. A., Page I. H., Pick A., Kaplan B. M., Berkson B. M., Century D. Effects of long-term estrogen therapy on serum cholesterol-lipid-lipoprotein levels and on mortality in middle-aged men with previous myocardial infarction. Drugs Affecting Lipid Metabolism, S. Garratini, R. Paoletti. Elsevier, Amsterdam 1961; 443
   Google Scholar
• Furman R. H., Alaupovic P., Howard R. P. Effects of androgens and estrogens on serum lipids and the composition and concentration of serum lipoproteins in normolipemic and hyperlipidemic states. Prog. Biochem. Pharmacol 1967; 215: 2
   Google Scholar
• Furman R. H. Gonadal steroid effects on serum lipids. Metabolic Effects of Gonadal Hormones and Contraceptive Steroids, H. A. Salhanick, D. M. Kipnis, R. I. Varde Wiele. Plenum Press., New York 1969; 247
   Google Scholar
• Wallace R. B., Hoover J., Barrett-Connor E., Rifkind B. M., Hunninghake D. B., Mackenthun A., Heiss G. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Report from the medications working group of the lipid research clinics program. Lancet 1979; 2: III
   Web of Science ®Google Scholar
• Arntzenius A. C, Van Gent C. M., Van der Voort H., Stegerholk C. I., Styblo K. Reduced high-density lipoprotein in women aged 40-41 using oral contraceptives. Consultation bureau heart project. Lancet 1978; I: 1221
   Google Scholar
• Bradley D. D., Wingerd J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N. Engl. J. Med. 1978; 299: 17
   PubMed Web of Science ®Google Scholar
• Krauss R. M., Lindgren F. T., Wingerd J., Bradley D. D., Ramcharan S. Effects of estrogens and progestins on high density lipoproteins. Lipids 1979; 14: 113
   PubMed Web of Science ®Google Scholar
• Bolton C. H., Elwood M., Hartog M., Martin R., Rowe A. S., Wensley R. T. Comparison of the effects of ethinyloestradiol and conjugated equine oestrogens in oophorectomised women. Clin. End. 1975; 4: 131
   PubMed Web of Science ®Google Scholar
• Nikkilä E. A., Kaste M., Ehnholm C, Viikari J. Increase of serum high-density-lipoprotein in phenytoin users. Br. Med. J. 1978; 2: 99
   PubMed Web of Science ®Google Scholar
• Luoma P. V., Myllyl'a V. V., Sotaniemi E. A., Hokkanen T. E. J. Plasma HDL cholesterol in epileptics with elevated triglyceride and cholesterol. Acta Neurol. Scand. 1979; 60: 56
   PubMed Web of Science ®Google Scholar
• Durringlon P. N. Effect of phenobarbitone on plasma apolipoprotein B and plasma high-density lipoprotein cholesterol in normal subjects. Clin. Sci. 1979; 56: 501
   Web of Science ®Google Scholar
• Luoma P. V., Sotaniemi E. A., Pelkonen R. O., Myllyl'a V. V. Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment. Scand. J. Clin. Lab. Invest. 1980; 40: 163
   PubMed Web of Science ®Google Scholar
• Carlson L. A., Kolmodin-Hedman B. Hyper-a-lipoproteinaemia in men exposed to chlorinated hydrocarbon pesticides. Ada Med. Scand. 1972; 192: 29
   PubMedGoogle Scholar
• Jones A. L., Armstrong D. T. Increased cholesterol biosynthesis following phenobarbital-induced hypertrophy of agranular endoplasmic reticulum in liver. Proc. Soc. Exp. Biol. Med. 1965; 19: 1136
   Google Scholar
• Wada F., Hirata K., Sakamoto Y. Relation of cholesterol synthesis and NADPH oxidation by microsomal electron transport system involving P-450. Biochim. Biophys. Acta 1967; 143: 273
   Google Scholar
• Middleton W. R. J., Isselbacher K. J. The stimulation of intestinal cholesterogenesis in the rat by phenobarbital. Proc. Soc. Exp. Biol. Med. 1969; 131: 1435
   PubMed Web of Science ®Google Scholar
• Wada F., Hirata K., Nakao K., Sakamoto Y. Participation of P-450 in 7α-hydroxylation of cholesterol. J. Biochem. 1968; 64: 415
   PubMed Web of Science ®Google Scholar
• Shefer S., Hauser S., Mosbach E. H. Stimulation of cholesterol 7α-hydroxylase by phenobarbital in two strains of rats. J. Lipid Res. 1972; 13: 69
   PubMed Web of Science ®Google Scholar
• Redinger R. N., Small D. M. Primate biliary physiology VIII. The effect of phenobarbital upon bile salt synthesis and pool size, biliary lipid secretion and bile composition. J. Clin. Invest. 1973; 52: 161
   PubMed Web of Science ®Google Scholar
• Linden V. Myocardial infarction in epileptics. Br. Med. J. 1975; 2: 87
   PubMed Web of Science ®Google Scholar
• Livingston S. Phenytoin and serum cholesterol. Br. Med. J. 1976; I: 586
   Google Scholar
• Bolli P., Stachlein H., Buhler F. R. Effect on plasma lipid fractions of long-term antihypertensive therapy with slow exprenolol. C1BA symposium: The Clinical Impact of Beta-adrenoceptor Blockade, B. M. Burley, G. F. B. Birdwood. C1BA Laboratories, Horsham, West Sussex 1980; 41
   Google Scholar
• Helgoland A, Hjermann I., Leren P., Enger S., Holme I. High-density lipoprotein cholesterol and antihypertensive drugs: the Oslo study. Br. Med. J. 1978; 2: 403
   PubMed Web of Science ®Google Scholar
• Kirkendall J. C, Overturf M. L., Zamma A. Prazocin and clonidine for moderately severe hypertension. JAMA 1978; 240: 2553
   PubMed Web of Science ®Google Scholar
• Bauer J. H., Brooks C. S., Weinstein I., Wilcox H., Heinberg M. Comparison of ticrynafen and hydrochlorothiazide on plasma lipids. Circulation 1979; 59: II
   Google Scholar
• Solyom A. Effects of androgens on serum lipids and lipoproteins. Lipids 1972; 7: 100
   PubMed Web of Science ®Google Scholar
• Bell G. D., Bradshaw J. P., Burgess A., Ellis W., Halton J., Middleton A., Middleton B., Orchard T., White D. A. Elevation of serum high density lipoprotein cholesterol by rowachol, a proprietary mixture of six pure monotoperes. Atherosclerosis 1980; 36: 47
   PubMed Web of Science ®Google Scholar
• Hermann W. J., Ward K., Faucett J. The effects of tocopherol on high-density lipoprotein cholesterol. A clinical observation. Am. J. Clin. Path. 1979; 72: 848
   PubMed Web of Science ®Google Scholar
• Horsey J., Livesley B., Dickerson J. W. T. Ischaemic heart disease and aged patients: effects of ascorbic acid on lipoproteins. Human Nutr. 1981; 35: 53
   PubMedGoogle Scholar
• University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onse diabetes. JAMA 1971; 218: 1400
   PubMed Web of Science ®Google Scholar
• Editorial. Oral hypoglycaemics in diabetes mellitus. Lancet 1975; 2: 489
   Google Scholar
• Lopes-Virella M. F. L., Stone P. G., Colwell J. A. Serum high-density lipoprotein in diabetic patients. Diabetologia 1977; 13: 285
   PubMed Web of Science ®Google Scholar
• Calvert G. D., Graham J. J., Mannik T., Wise P. H., Yeates R. A. Effects of therapy on plasma-high-density-lipoprotein-cholesterol concentration in diabetes mellitus. Lancet 1978; 2: 66
   PubMed Web of Science ®Google Scholar
• Bunn H. F., Gabbay K. H., Gallop P. M. The glycosylation of hemoglobin: relevance to diabetes. Science 1978; 200: 21
   PubMed Web of Science ®Google Scholar
• Molnar G. D., Marien G. J., Hunter A. N., Harley C. H. Methods of assessing diabetic control. Diabetologia 1979; 17: 5
   PubMed Web of Science ®Google Scholar
• Lisch H-J., Sailer S. Lipoprotein patterns in diet, sulphonylurea and insulin treated diabetics. Diabetologia 1981; 20: 118
   PubMed Web of Science ®Google Scholar
• Paisey R., Elkeles R. S., Hambley J., Magill P. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia 1978; 15: 81
   PubMed Web of Science ®Google Scholar
• Kennedy A. L., Lappin T. R. J., Lavery T. D., Hadden D. R., Weaver J. A., Montgomery D. A. D. Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control. Br. Med. J. 1978; 2: 1191
   PubMed Web of Science ®Google Scholar
• Nikkilä E. A., Hormila P. Serum lipids and lipoproteins in insulin-treated diabetes. Demonstration of increased high density lipoprotein concentrations. Diabetes 1978; 27: 1078
   PubMed Web of Science ®Google Scholar
• Mattock N. B., Fuller J. H., Maude P. S., Keen H. Lipoproteins and plasma cholesterol esterification in normal and diabetic subjects. Atherosclerosis 1979; 34: 437
   PubMed Web of Science ®Google Scholar
• St Leger A. S., Cochrane A. L., Moore F. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979; 2: 1017
   Google Scholar
• Sosenko J. M., Breslow J. L., Miettinen O. S., Cabbay K. H. Hyperglycaemia and plasma lipid levels. A prospective study of young insulin-dependent diabetic patients. N. Engl. J. Med. 1980; 302: 650
   PubMed Web of Science ®Google Scholar
• Misra D. P., Staddon G., Powell N., Misra J., Crook D. Lecithin-cholesterol acyltransferase activity in diabetes mellitus and the effect of insulin in these cases. Clin. Chim. Acta 1974; 56: 83
   PubMed Web of Science ®Google Scholar
• Field J. B. Extraction of insulin by liver. Ann. Rev. Med. 1973; 24: 309
   PubMed Web of Science ®Google Scholar
• Felig P., Soman V. Insulin receptors in diabetes and other conditions. Am. J. Med. 1979; 67: 913
   PubMed Web of Science ®Google Scholar
• Johansson B. G., Nilsson-Ehle P. Alcohol consumption and high density lipoprotein. N. Engl. J. Med. 1978; 298: 633
   PubMed Web of Science ®Google Scholar
• Jarrett J. Diabetes and the heart: coronary heart disease. Clin. End. Metab. 1978; 6: 389
   Google Scholar
• Cahill G. F., Etzwiler D. D., Frienkel N. 'Control'and diabetes. N. Engl. J. Med. 1976; 294: 1004
   PubMed Web of Science ®Google Scholar
• Eckel R. H., Albers J. J., Cheung M. C., Wahl P. W., Lindgren F. T., Bierman E. L. High density lipoprotein composition in insulin-dependent diabetes mellitus. Diabetes 1981; 30: 132
   PubMed Web of Science ®Google Scholar
• Durrington P. N. Serum high density lipoprotein cholesterol subfractions in type I (insulin-dependent) mellitus. Clin. Chim. Acta 1982; 120: 21
   PubMed Web of Science ®Google Scholar
• Reckless J. P. D., Betteridge Wu P., Payne B., Galton D. J. High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br. Med. J. 1978; 1: 883
   PubMed Web of Science ®Google Scholar
• Agdeppa D., Macaron C, Mallik T., Schnuda N. D. Plasma high density lipoprotein cholesterol in thyroid disease. J. Clin. Endocrinol. Metab. 1979; 49: 726
   PubMed Web of Science ®Google Scholar
• Scottolini A. G., Bhagavan N. V., Oshira T. H., Abe S. V. Serum high-density lipoprotein cholesterol concentrations in hypo-and hyperthyroidism. Clin. Chem. 1980; 26: 584
   PubMed Web of Science ®Google Scholar
• von Wieland H., Seidel D. Plasma lipoprotein bei patienten mit hyperthyreose: isolierung und charakterisierung eines abnormen high-density lipoproteins. J. Klin. Chem. Klin. Biochem. 1972; 10: 311
   Google Scholar
• Tulloch B. R., Lewis B., Fraser T. R. Triglyceride metabolism in thyroid disease. Lancet 1973; 1: 391
   PubMed Web of Science ®Google Scholar
• Rössner S., Rosenqvist V. Serum lipoproteins and the intravenous fat tolerance test in hypothyroid patients before and during substitution therapy. Atherosclerosis 1974; 20: 365
   PubMed Web of Science ®Google Scholar
• Suenram A., McConathy W. J., Alaupovic P. Evidence for the lipoprotein heterogeneity of human plasma high density lipoproteins isolated by three different procedures. Lipids 1979; 14: 505
   PubMed Web of Science ®Google Scholar
• Sagel J., Lopes-Virella M. F., Levin J. H., Colwell J. A. Decreased high density lipoprotein cholesterol in hypopituitarism. J Clin. Endocrinol. Metab. 1979; 49: 753
   PubMed Web of Science ®Google Scholar
• Gherardi E., Rota E., Calandra S., Genova R., Tamorino A. Relationship among the concentrations of serum lipoproteins and changes in their chemical composition in patients with untreated nephrotic syndrome. Eur. J. Clin. Invest. 1977; 7: 563
   PubMed Web of Science ®Google Scholar
• Brunzell J. D., Albers J. J., Haas L. B., Goldberg A. P., Agadoa L., Sherrard D. J. Prevalence of serum lipid abnormalities in chronic haemodialysis. Metabolism 1977; 26: 903
   PubMed Web of Science ®Google Scholar
• Bagdade J. D., Albers J. J. Plasma high-density lipoprotein concentration in chronic-haemodialysis and renal-transplant patients. N. Engl. J. Med. 1977; 296: 1436
   PubMed Web of Science ®Google Scholar
• Rapaport J., Aviram M., Chaimovitz C, Brook J. G. Definitive high-density lipoprotein composition in patients on chronic haemodialysis. A possible mechanism for accelerated atherosclerosis. N. Engl J. Med. 1978; 299: 1326
   PubMed Web of Science ®Google Scholar
• Tisi G. M., Conrique A., Barret-Connor E., Grundy S. M. Increased high density lipoprotein cholesterol in obstructive pulmonary disease (predominant emphysematous type). Metabolism 1981; 30: 340
   PubMed Web of Science ®Google Scholar
• Nestel P. J., Podkrolinski M., Fidge N. H. Marked increase in high density lipoproteins in mountaineers. Atherosclerosis 1979; 34: 193
   PubMed Web of Science ®Google Scholar
• McLntyre N. Plasma lipids and lipoproteins in liver disease. Gut 1978; 19: 526
   PubMed Web of Science ®Google Scholar
• Sabesin S. M., Hawkins H. L., Kuiken L., Rogland J. B. Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease. Gastroenterology 1977; 510: 72
   Google Scholar
• Agorastos J., Fox C, Harry D. S., McLntyre N. Lecithin-cholesterol acyltransferase and the lipoprotein abnormalities of obstructive jaundice. Clin. Sci. Mol. Med. 1978; 54: 369
   PubMedGoogle Scholar
• Tada N., Fidge N. H., Nestel P. J. Identification and characterisation of mixed disulphide complexes of E apoproteins in high density lipoprotein of subjects with acute alcoholic hepatitis. Biochem. Biophys. Res. Commun. 1979; 90: 297
   PubMed Web of Science ®Google Scholar
• Nestel P. J., Tada N., Fidge N. H. Increased catabolism of high density lipoprotein in alcoholic hepatitis. Metabolism 1980; 29: 101
   PubMed Web of Science ®Google Scholar
• Schwartz C. C, Halloran L. G., Vlahcevic Z. R., Gregory D. H., Swell L. Preferential utilization of free cholesterol from high-density lipoproteins for biliary cholesterol secretion in man. Science 1978; 62: 200
   Google Scholar
• Halloran L. C, Schwartz C. C., Vlahcevic Z. R., Nisman R. M., Swell L. Evidence for high density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man. Surgery 1978; 84: I
   Web of Science ®Google Scholar
• Anderson A., James O. F. W., MacDonald H. S., Snowball S., Taylor W. The effect of ethinyl oestradiol on biliary lipid composition in young men. Eur. J. Clin. Invest. 1980; 10: 77
   PubMed Web of Science ®Google Scholar
• Thornton J. R., Heaton K. W., MacFarlane D. G., Bolton C. H. Bile saturation and plasma lipids: a relationship with high density lipoproteins. Gut. 1979; 20: A931
   Web of Science ®Google Scholar
• Einarsson K., Hellstrom K., Kallner M. Gallbladder disease in hyperlipoproteinaemia. Lancet 1975; 484: 1
   Google Scholar
• Rössner S., Lofmark C. Dyslipoproteinacmia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis 1977; 41: 28
   Google Scholar
• Rössner S. Further studies on serum lipoproteins in connective tissue diseases. Atherosclerosis 1978; 31: 93
   PubMed Web of Science ®Google Scholar
• Sniderman A., Shapiro S., Marpole D., Skinner B., Teng B., Kwiterovich P. O. Association of coronary atherosclerosis with hyperapobetalipoproteinaemia (increased protein but normal cholesterol levels in human plasma low density (β) lipoproteins). Proc. Natl. Acad. Sci. U.S.A. 1980; 77: 604
   PubMed Web of Science ®Google Scholar
• Carlson L. A., Boltiger L. E. Ischaemic heart disease in relation to fasting values of plasma triglyceride and cholesterol. Lancet 1972; i: 865
   Google Scholar
• Keys A. Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet 1980; 603: 11
   Google Scholar
• Friedwald W. T., Levy R. I., Fredrickson D. S. Estimation of serum low density lipoprotein cholesterol concentration without use of the preparative ultracentrifuge. Clin. Chem. 1972; 18: 499
   PubMed Web of Science ®Google Scholar
• Lopes-Virella M., Virella G., de Beukelaer M, Owens C. J., Colwell J. A. Urinary high density lipoproteins in minimal change disease and chronic glomerulonephritis. Clin. Chim. Acta 1979; 94: 73
   PubMed Web of Science ®Google Scholar
• Wass V. J., Jarrett R. J., Chilvers C., Cameron J. S. Does the nephrotic syndrome increase the risk of cardiovascular disease?. Lancet 1979; 2: 664
   PubMed Web of Science ®Google Scholar
• Ballantyne D., Ballantyne F. C., McMurdo M. Effect of slow oxprenolol and a combination of slow exprenolol and cyclopenthiazide on plasma lipoproteins. Atherosclerosis 1981; 39: 301
   PubMed Web of Science ®Google Scholar
• Leren P., Foss O. P., Helgeland A., Hjermann I., Holme I. Effects of pindolol and hydrochlorothiazide on blood lipids - The Oslo study. Clin. Trials J. 1981; 18: 254
   Google Scholar
• Nicholls A. J., Cumming A. M., Catto G. R. D., Edward N., Engeset J. Lipid relationships in dialysis and renal transplant patients. Q. J. Med. 1981; 50: 149
   PubMedGoogle Scholar
• Nicoll A., Miller N. E., Lewis B. High density lipoprotein metabolism. Adv. Lipid Pes. 1980; 17: 53
   PubMedGoogle Scholar
• Tall A. R., Small D. M. Body cholesterol removal: role of plasma high-density lipoproteins. Adv. Lipid Res. 1980; 17: I
   Google Scholar
• Schaefer E. J., Foster D. M., Jenkins L. J., Lindgren F. T., Berman M., Levy R. I. The composition and metabolism of high density lipoprotein subftactions. Lipids 1979; 511: 14
   Google Scholar